{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:07:09Z","timestamp":1772809629692,"version":"3.50.1"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Lanthionine synthetase C\u2013like 2 (LANCL2) is an immunoregulatory therapeutic target for autoimmune diseases. NIM-1324 is an investigational new drug aimed at addressing the unmet clinical needs of patients with systemic lupus erythematosus (SLE) by targeting the LANCL2 immunometabolic pathway. In R848 and bm12 adoptive transfer models of systemic inflammation that share pathologies with SLE, Lancl2\u2212\/\u2212 mice experienced greater mortality, increased spleen weight, and reduced CD25hi FOXP3+ CD4+ regulatory T cells compared with the wild type. Conversely, treatment with NIM-1324 in the wild type increased CD25hi FOXP3+ regulatory T cells while reducing inflammatory IL-17+ and IL-21+ CD4+ T cell subsets in the spleen. In traditional mouse models of SLE (NZB\/W F1 and MRL\/lpr), oral treatment with NIM-1324 protected against weight loss and proteinuria, decreased anti-dsDNA titers, and provided similar changes to the CD4+ T cell compartment in the spleen. The pharmacological activation of LANCL2 by NIM-1324 rescued hypocomplementemia, reduced kidney histopathological scores, and decreased blood IFN response genes and inflammatory cytokines. The loss of LANCL2 in phagocytes impairs phagosome processing, leading to increased uptake of material and inflammatory cytokine production, yet decreased markers of endosomal maturation, phagosome turnover, and lysozyme activity. Treatment with NIM-1324 increases metabolic and lysozyme activity in the phagosome, providing support for increased markers of early phagosome function. This efficacy translated to human PBMCs from patients with SLE, because ex vivo treatment with NIM-1324 resulted in reduced levels of IFN-\u03b1, IL-6, and IL-8. Consequently, the activation of LANCL2 effectively modulates CD4+ T cell differentiation and phagocyte activation, supporting immune tolerance in SLE.<\/jats:p>","DOI":"10.4049\/jimmunol.2400127","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T13:31:37Z","timestamp":1728048697000},"page":"1429-1440","source":"Crossref","is-referenced-by-count":2,"title":["Immunometabolic Mechanisms of LANCL2 in CD4+ T Cells and Phagocytes Provide Protection from Systemic Lupus Erythematosus"],"prefix":"10.1093","volume":"213","author":[{"given":"Andrew","family":"Leber","sequence":"first","affiliation":[{"name":"NIMML Institute , Blacksburg, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Hontecillas","sequence":"additional","affiliation":[{"name":"NIMML Institute , Blacksburg, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Tubau-Juni","sequence":"additional","affiliation":[{"name":"NIMML Institute , Blacksburg, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah N","family":"Fitch","sequence":"additional","affiliation":[{"name":"NIMML Institute , Blacksburg, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Bassaganya-Riera","sequence":"additional","affiliation":[{"name":"NIMML Institute , Blacksburg, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"2025020609292284300_r1","first-page":"330","article-title":"Manifestations of systemic lupus erythematosus","volume":"6","author":"Cojocaru","year":"2011","journal-title":"Maedica (Bucur)"},{"key":"2025020609292284300_r2","doi-asserted-by":"crossref","first-page":"11286","DOI":"10.3390\/ijms222011286","article-title":"The pathogenesis, molecular mechanisms, and therapeutic potential of the interferon pathway in systemic lupus erythematosus and other autoimmune diseases","volume":"22","author":"Ramaswamy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2025020609292284300_r3","doi-asserted-by":"crossref","first-page":"1007078","DOI":"10.3389\/fimmu.2022.1007078","article-title":"Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus","volume":"13","author":"Ohmes","year":"2022","journal-title":"Front. Immunol."},{"key":"2025020609292284300_r4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/eji.201344280","article-title":"Regulatory T cells in systemic lupus erythematosus","volume":"45","author":"Ohl","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"2025020609292284300_r5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-0-387-72005-0_12","article-title":"Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus","volume":"601","author":"Lyssuk","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"2025020609292284300_r6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int. Immunol."},{"key":"2025020609292284300_r7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/ard.2007.083543","article-title":"Clinical significance of increased CD4+CD25\u2212Foxp3+ T cells in patients with new-onset systemic lupus erythematosus","volume":"67","author":"Zhang","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"2025020609292284300_r8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11926-001-0018-1","article-title":"Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus","volume":"3","author":"Navratil","year":"2001","journal-title":"Curr. Rheumatol. Rep."},{"key":"2025020609292284300_r9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(64)91163-8","article-title":"Lysosomes, autoimmune phenomena, and diseases of connective tissue","volume":"2","author":"Weissmann","year":"1964","journal-title":"Lancet"},{"key":"2025020609292284300_r10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ng.468","article-title":"A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus","volume":"41","author":"Gateva","year":"2009","journal-title":"Nat. Genet."},{"key":"2025020609292284300_r11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.81","article-title":"Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"Harley","year":"2008","journal-title":"Nat. Genet."},{"key":"2025020609292284300_r12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/ard.2005.037143","article-title":"Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells","volume":"65","author":"Tas","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"2025020609292284300_r13","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/art.11237","article-title":"Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus","volume":"48","author":"Ren","year":"2003","journal-title":"Arthritis Rheum."},{"key":"2025020609292284300_r14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.0901322","article-title":"Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus","volume":"184","author":"Jorgensen","year":"2010","journal-title":"J. Immunol."},{"key":"2025020609292284300_r15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1027399027170","article-title":"Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis","volume":"21","author":"Fan","year":"1997","journal-title":"Inflammation"},{"key":"2025020609292284300_r16","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.4049\/jimmunol.133.4.1955","article-title":"Studies of lymphoproliferation in MRL-lpr\/lpr mice","volume":"133","author":"Smathers","year":"1984","journal-title":"J. Immunol."},{"key":"2025020609292284300_r17","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.4049\/jimmunol.1203525","article-title":"Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1","volume":"190","author":"Nickerson","year":"2013","journal-title":"J. Immunol."},{"issue":"105","key":"2025020609292284300_r18","first-page":"e53319","article-title":"The bm12 inducible model of systemic lupus erythematosus (SLE) in C57BL\/6 mice","author":"Klarquist","year":"2015","journal-title":"J. Vis. Exp."},{"key":"2025020609292284300_r19","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1074\/jbc.M110.160077","article-title":"Abscisic acid regulates inflammation via ligand-binding domain-independent activation of PPAR gamma","volume":"286","author":"Bassaganya-Riera","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2025020609292284300_r20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnut.2017.00024","article-title":"Abscisic acid: a novel nutraceutical for glycemic control","volume":"4","author":"Zocchi","year":"2017","journal-title":"Front. Nutr."},{"key":"2025020609292284300_r21","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/ibd\/izy167","article-title":"Activation of LANCL2 by BT-11 ameliorates IBD by supporting regulatory T cell stability through immunometabolic mechanisms","volume":"24","author":"Leber","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"2025020609292284300_r22","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.1801446","article-title":"Oral treatment with BT-11 ameliorates inflammatory bowel disease by enhancing regulatory T cell responses in the gut","volume":"202","author":"Leber","year":"2019","journal-title":"J. Immunol."},{"key":"2025020609292284300_r23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1074\/mcp.RA118.001259","article-title":"Streamlined protocol for deep proteomic profiling of FAC-sorted cells and its application to freshly isolated murine immune cells","volume":"18","author":"Myers","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"2025020609292284300_r24","first-page":"S821","article-title":"Efficacy and safety of omilancor in a phase 2 randomized, double-blind, placebo-controlled trial of patients with ulcerative colitis [abstract]","volume":"118","author":"Leber","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"2025020609292284300_r25","doi-asserted-by":"crossref","first-page":"S820","DOI":"10.14309\/01.ajg.0000953944.51931.e5","article-title":"Efficacy and safety of omilancor in a phase 2 randomized, double-blind, placebo-controlled trial of patients with Crohn\u2019s disease [abstract]","volume":"118","author":"Leber","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"2025020609292284300_r26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ibd\/izad258","article-title":"Treating autoimmune diseases with LANCL2 therapeutics: a novel immunoregulatory mechanism for patients with ulcerative colitis and Crohn\u2019s disease","volume":"30","author":"Tubau-Juni","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"2025020609292284300_r27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/nu11081757","article-title":"Abscisic acid standardized fig (Ficus carica) extracts ameliorate postprandial glycemic and insulinemic responses in healthy adults","volume":"11","author":"Atkinson","year":"2019","journal-title":"Nutrients"},{"key":"2025020609292284300_r28","doi-asserted-by":"crossref","first-page":"676058","DOI":"10.3389\/fmed.2021.676058","article-title":"Serum concentration of the phytohormone abscisic acid is associated with immune-regulatory mediators and is a potential biomarker of disease severity in chronic obstructive pulmonary disease","volume":"8","author":"Hoang","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"2025020609292284300_r29","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.3390\/ijms21228425","article-title":"Phytohormone abscisic acid improves memory impairment and reduces neuroinflammation in 5xFAD mice by upregulation of LanC-Like protein 2","volume":"21","author":"Jeon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2025020609292284300_r30","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/cells11182888","article-title":"The ABA-LANCL1\/2 hormone-receptors system protects H9c2 cardiomyocytes from hypoxia-induced mitochondrial injury via an AMPK- and NO-mediated mechanism","volume":"11","author":"Spinelli","year":"2022","journal-title":"Cells"},{"key":"2025020609292284300_r31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0961203313492577","article-title":"Limitations of current treatments for systemic lupus erythematosus: a patient and physician survey","volume":"22","author":"Strand","year":"2013","journal-title":"Lupus"},{"key":"2025020609292284300_r32","first-page":"2337","article-title":"Safety and tolerability of NIM-1324, an oral, once-daily LANCL2 agonist, in a randomized, double-blind, placebo-controlled phase 1 study in normal healthy volunteers [abstract]","volume":"75","author":"Leber","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"2025020609292284300_r33","doi-asserted-by":"crossref","first-page":"e0167440","DOI":"10.1371\/journal.pone.0167440","article-title":"Modeling the role of lanthionine synthetase C-like 2 (LANCL2) in the modulation of immune responses to Helicobacter pylori infection","volume":"11","author":"Leber","year":"2016","journal-title":"PLoS One"},{"key":"2025020609292284300_r34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4049\/jimmunol.1701588","article-title":"TLR7-mediated lupus nephritis is independent of type I IFN signaling","volume":"201","author":"Wolf","year":"2018","journal-title":"J. Immunol."},{"key":"2025020609292284300_r35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1073\/pnas.0903158107","article-title":"Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus","volume":"107","author":"Humrich","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2025020609292284300_r36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4049\/jimmunol.177.3.1451","article-title":"Suppression of disease in New Zealand Black\/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells","volume":"177","author":"Scalapino","year":"2006","journal-title":"J. Immunol."},{"key":"2025020609292284300_r37","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/ar4188","article-title":"CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice","volume":"15","author":"Weigert","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"2025020609292284300_r38","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.cell.2011.12.006","article-title":"Metabolic connections during apoptotic cell engulfment","volume":"147","author":"Han","year":"2011","journal-title":"Cell"},{"key":"2025020609292284300_r39","doi-asserted-by":"crossref","first-page":"10463","DOI":"10.1038\/s41598-020-67300-2","article-title":"Abscisic acid enriched fig extract promotes insulin sensitivity by decreasing systemic inflammation and activating LANCL2 in skeletal muscle","volume":"10","author":"Leber","year":"2020","journal-title":"Sci. Rep."},{"key":"2025020609292284300_r40","doi-asserted-by":"crossref","first-page":"100147","DOI":"10.1016\/j.cellin.2024.100147","article-title":"STING guides the STX17-SNAP29-VAMP8 complex assembly to control autophagy","volume":"3","author":"Song","year":"2024","journal-title":"Cell Insight"},{"key":"2025020609292284300_r41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature17950","article-title":"Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells","volume":"533","author":"Martinez","year":"2016","journal-title":"Nature"},{"key":"2025020609292284300_r42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/cei.13566","article-title":"Variety of endosomal TLRs and Interferons (IFN-alpha, IFN-beta, IFN-gamma) expression profiles in patients with SLE, SSc and MCTD","volume":"204","author":"Paradowska-Gorycka","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"2025020609292284300_r43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/ard.2005.035733","article-title":"Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement","volume":"65","author":"Bijl","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"2025020609292284300_r44","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.4049\/jimmunol.1401129","article-title":"Selective memory to apoptotic cell-derived self-antigens with implications for systemic lupus erythematosus development","volume":"197","author":"Duhlin","year":"2016","journal-title":"J. Immunol."},{"key":"2025020609292284300_r45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","article-title":"Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity","volume":"166","author":"Sisirak","year":"2016","journal-title":"Cell"},{"key":"2025020609292284300_r46","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type I interferon-mediated autoinflammation due to DNase II deficiency","volume":"8","author":"Rodero","year":"2017","journal-title":"Nat. Commun."},{"key":"2025020609292284300_r47","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2025020609292284300_r48","first-page":"420","article-title":"Metabolic reprograming in macrophage polarization","volume":"5","author":"Galvan-Pena","year":"2014","journal-title":"Front. Immunol."},{"key":"2025020609292284300_r49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3899\/jrheum.2023-0833","article-title":"The link between dysregulated immunometabolism and vascular damage: implications for the development of atherosclerosis in systemic lupus erythematosus and other rheumatic diseases","volume":"51","author":"Yennemadi","year":"2024","journal-title":"J. Rheumatol."},{"key":"2025020609292284300_r50","doi-asserted-by":"crossref","first-page":"104741","DOI":"10.1016\/j.cellimm.2023.104741","article-title":"Chronic IFNalpha treatment induces leukopoiesis, increased plasma succinate and immune cell metabolic rewiring","volume":"390","author":"Yennemadi","year":"2023","journal-title":"Cell. Immunol."},{"key":"2025020609292284300_r51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","article-title":"Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell. Metab."},{"key":"2025020609292284300_r52","doi-asserted-by":"crossref","first-page":"106841","DOI":"10.1016\/j.imlet.2024.106841","article-title":"The phagocytosis dysfunction in lupus nephritis is related to monocyte\/macrophage CPT1a","volume":"266","author":"Jativa","year":"2024","journal-title":"Immunol. Lett."},{"key":"2025020609292284300_r53","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/antiox12091692","article-title":"Abscisic acid and its receptors LANCL1 and LANCL2 control cardiomyocyte mitochondrial function, expression of contractile, cytoskeletal and ion channel proteins and cell proliferation via ERRalpha","volume":"12","author":"Spinelli","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"2025020609292284300_r54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopha.2015.02.017","article-title":"Update on the role of autophagy in systemic lupus erythematosus: a novel therapeutic target","volume":"71","author":"Pan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"2025020609292284300_r55","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s40620-023-01733-6","article-title":"Hydroxychloroquine in nephrology: current status and future directions","volume":"36","author":"Rao","year":"2023","journal-title":"J. Nephrol."},{"key":"2025020609292284300_r56","doi-asserted-by":"crossref","first-page":"40817","DOI":"10.18632\/oncotarget.17256","article-title":"Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFkappaB pathways in autophagy- and p62-dependent manners","volume":"8","author":"Ko","year":"2017","journal-title":"Oncotarget"},{"key":"2025020609292284300_r57","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1080\/15548627.2018.1495681","article-title":"The autophagy receptor SQSTM1\/p62 mediates anti-inflammatory actions of the selective NR3C1\/glucocorticoid receptor modulator compound A (CpdA) in macrophages","volume":"14","author":"Mylka","year":"2018","journal-title":"Autophagy"},{"key":"2025020609292284300_r58","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1111\/jcmm.16593","article-title":"Cyclosporine A blocks autophagic flux in tubular epithelial cells by impairing TFEB-mediated lysosomal function","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"2025020609292284300_r59","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"2025020609292284300_r60","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/annrheumdis-2021-221295","article-title":"Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort","volume":"81","author":"Almeida-Brasil","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"2025020609292284300_r61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13075-017-1397-7","article-title":"Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity","volume":"19","author":"Ikeda","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"2025020609292284300_r62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0961203307088289","article-title":"Rapamycin prevents the development of nephritis in lupus-prone NZB\/W F1 mice","volume":"17","author":"Lui","year":"2008","journal-title":"Lupus"},{"key":"2025020609292284300_r63","doi-asserted-by":"crossref","first-page":"1759720X20953336","DOI":"10.1177\/1759720X20953336","article-title":"Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis","volume":"12","author":"Peng","year":"2020","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"2025020609292284300_r64","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","article-title":"Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4\u2212CD8\u2212 double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus","volume":"192","author":"Kato","year":"2014","journal-title":"J. Immunol."},{"key":"2025020609292284300_r65","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1096\/fj.12-206060","article-title":"T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy","volume":"26","author":"Alessandri","year":"2012","journal-title":"FASEB J."},{"key":"2025020609292284300_r66","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.4049\/jimmunol.0901662","article-title":"Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression: mechanism of ciprofloxacin-mediated immunosuppression","volume":"184","author":"Kaminski","year":"2010","journal-title":"J. Immunol."},{"key":"2025020609292284300_r67","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"key":"2025020609292284300_r68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","article-title":"Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus","volume":"46","author":"Gergely","year":"2002","journal-title":"Arthritis Rheum."},{"key":"2025020609292284300_r69","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/BOR.0000000000000413","article-title":"Metabolic abnormalities and oxidative stress in lupus","volume":"29","author":"Lightfoot","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"2025020609292284300_r70","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4049\/jimmunol.1200411","article-title":"Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor gamma","volume":"189","author":"Perry","year":"2012","journal-title":"J. Immunol."},{"key":"2025020609292284300_r71","doi-asserted-by":"crossref","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"2025020609292284300_r72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4049\/jimmunol.1501537","article-title":"Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus","volume":"196","author":"Yin","year":"2016","journal-title":"J. Immunol."},{"key":"2025020609292284300_r73","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1038\/s41467-018-06686-0","article-title":"Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells","volume":"9","author":"Choi","year":"2018","journal-title":"Nat. Commun."},{"key":"2025020609292284300_r74","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1172\/JCI22854","article-title":"Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV","volume":"115","author":"Juang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2025020609292284300_r75","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.40785","article-title":"Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus","volume":"71","author":"Koga","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"2025020609292284300_r76","doi-asserted-by":"crossref","first-page":"eaba5264","DOI":"10.1126\/sciimmunol.aba5264","article-title":"An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice","volume":"5","author":"Khoryati","year":"2020","journal-title":"Sci. Immunol."},{"key":"2025020609292284300_r77","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.aal3908","article-title":"A switch from canonical to noncanonical autophagy shapes B cell responses","volume":"355","author":"Martinez-Martin","year":"2017","journal-title":"Science"},{"key":"2025020609292284300_r78","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1080\/15548627.2022.2113296","article-title":"Transcriptomic analysis of pathways associated with ITGAV\/alpha(v) integrin-dependent autophagy in human B cells","volume":"19","author":"Muir","year":"2023","journal-title":"Autophagy"},{"key":"2025020609292284300_r79","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.42091","article-title":"B cell-specific deletion of CR6-interacting factor 1 drives lupus-like autoimmunity by activation of interleukin-17, interleukin-6, and pathogenic follicular helper T cells in a mouse model","volume":"74","author":"Park","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"2025020609292284300_r80","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1073\/pnas.1204509109","article-title":"Apoptotic marginal zone deletion of anti-Sm\/ribonucleoprotein B cells","volume":"109","author":"Kishi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2025020609292284300_r81","doi-asserted-by":"crossref","first-page":"14789","DOI":"10.1038\/s41598-021-93034-w","article-title":"Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus","volume":"11","author":"Kingsmore","year":"2021","journal-title":"Sci. Rep."},{"key":"2025020609292284300_r82","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fimmu.2017.00178","article-title":"Lanthionine synthetase C-like 2 modulates immune responses to influenza virus infection","volume":"8","author":"Leber","year":"2017","journal-title":"Front. Immunol."},{"key":"2025020609292284300_r83","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ibd\/izad124","article-title":"Oral omilancor treatment ameliorates Clostridioides difficile infection during IBD through novel immunoregulatory mechanisms mediated by LANCL2 activation","volume":"30","author":"Tubau-Juni","year":"2024","journal-title":"Inflamm Bowel Dis."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/213\/10\/1429\/61754209\/ji2400127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/213\/10\/1429\/61754209\/ji2400127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T09:31:25Z","timestamp":1738834285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/213\/10\/1429\/7960654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,11,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.2400127","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,10,4]]}}}